Disease Specific Interactions between Host Protein and DME (HOSPPI) |
ICD Disease Classification Healthy |
ICD-11: Healthy |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
Oligomerization |
UDPGT 1-9 (UGT1A9) |
Health |
Heterooligomer |
Uniprot ID |
|
Interaction Name |
UGT1A9-UGT1A4 heterooligomerization |
[1] |
Studied Cell Lines |
Human embryonic kidney cell line (HEK293) |
Affected Substrate(s): |
Imipramine (Metabolic product: Imipramine N-glucuronide)
|
Activity |
Increasing Vmax and Km |
Description |
UDPGT 1-9 (UGT1A9) is reported to heterooligomerize with the UGT1A4 protein, which leads to an increased activity of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A4. As a result, the interaction between UGT1A9 and UGT1A4 can facilitate the drug-metabolizing process of UDP-glucuronosyltransferase 1A4. |
ICD Disease Classification 02 Neoplasms |
ICD-11: 2C12 Liver cancer |
Click to Show/Hide the Full List of HOSPPI: 2 HOSPPI
|
Transcription-factor regulation |
Estrogen receptor (ESR1) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
ESR1-UGT1A4 interaction |
[2] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Estrogen receptor (ESR1) is reported to activate the transcription of UGT1A4 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A4. As a result, the interaction between ESR1 and UGT1A4 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A4. |
Transcription factor Sp1 (SP1) |
Liver cancer |
Activation |
Uniprot ID |
|
Interaction Name |
SP1-UGT1A4 interaction |
[2] |
Studied Cell Lines |
HepG2 cell line |
Ensembl ID |
|
Description |
Transcription factor Sp1 (SP1) is reported to activate the transcription of UGT1A4 gene, which leads to an increased expression of the drug-metabolizing enzyme UDP-glucuronosyltransferase 1A4. As a result, the interaction between SP1 and UGT1A4 can activate the drug-metabolizing process of UDP-glucuronosyltransferase 1A4. |
|
|
|
|
|
|